Patient: Page 21


  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Industry at Large AstraZeneca and Diabetes Hands Foundation Partner to Help Adults Walk Their Way to Better Health AstraZeneca and the Diabetes Hands Foundation have launched Everyday Steps, a new campaign designed to help the almost 28 million Americans with type 2 diabetes develop and maintain ...

    By PharmaVoice Team • May 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Diagnosing CNS Diseases

    Neurological disorders comprise more than 600 conditions that affect the nervous system, impacting an estimated 50 million Americans every year. In the last few years, a tremendous push for new research of the brain has begun, in part, enabled by the National Institutes of Health BRAIN Initiative...

    By Denise Myshko • May 1, 2016
  • clinical trial diversity Explore the Trendline
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    India Stamps Its Mark on the Global Pharma Market

    India is one of the great economic success stories; the country has enjoyed rapid growth and development over recent years. Today, it is the world’s fourth-largest economy and according to the IMF, the country is expected to realize 7.5% GDP in 2016-2017. With 1.2 billion people, India has the se...

    By Kim Ribbink • May 1, 2016
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Preparing for an Outcomes-based Sales Model

    According to a recent report by Accenture, three factors — reimbursement models, changing buyer profiles, and digital capabilities — are changing the pharmaceutical and healthcare industries and directly impacting the traditional pharmaceutical sales rep model. However, these factors also represe...

    By Robin Robinson • March 1, 2016
  • Trendline

    Increasing diversity in clinical trials

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.